Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Aemetis stock | $19.96

Learn how to easily invest in Aemetis stock.

Aemetis Inc is an oil & gas refining & marketing business based in the US. Aemetis shares (AMTX) are listed on the NASDAQ and all prices are listed in US Dollars. Aemetis employs 164 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Aemetis

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aemetis stock price (NASDAQ: AMTX)

Use our graph to track the performance of AMTX stocks over time.

Aemetis shares at a glance

Information last updated 2021-10-23.
Latest market close$19.96
52-week range$1.96 - $27.44
50-day moving average $16.62
200-day moving average $13.79
Wall St. target price$30.83
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.21

Buy Aemetis shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aemetis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aemetis price performance over time

Historical closes compared with the close of $19.96 from 2021-10-22

1 week (2021-10-15) N/A
1 month (2021-09-24) 35.78%
3 months (2021-07-26) 101.41%
6 months (2021-04-26) 6.34%
1 year (2020-10-23) 396.52%
2 years (2019-10-25) 1,925.57%
3 years (2018-10-25) 2,168.18%
5 years (2016-10-25) 1,088.10%

Is Aemetis under- or over-valued?

Valuing Aemetis stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aemetis's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Aemetis's EBITDA

Aemetis's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $7.4 million.

The EBITDA is a measure of a Aemetis's overall financial performance and is widely used to measure a its profitability.

Aemetis financials

Revenue TTM $175.9 million
Gross profit TTM $11 million
Return on assets TTM -10.7%
Return on equity TTM 0%
Profit margin -31.53%
Book value $-6.52
Market capitalisation $632.5 million

TTM: trailing 12 months

Shorting Aemetis shares

There are currently 3.9 million Aemetis shares held short by investors – that's known as Aemetis's "short interest". This figure is 0.9% down from 4.0 million last month.

There are a few different ways that this level of interest in shorting Aemetis shares can be evaluated.

Aemetis's "short interest ratio" (SIR)

Aemetis's "short interest ratio" (SIR) is the quantity of Aemetis shares currently shorted divided by the average quantity of Aemetis shares traded daily (recently around 1.2 million). Aemetis's SIR currently stands at 3.35. In other words for every 100,000 Aemetis shares traded daily on the market, roughly 3350 shares are currently held short.

However Aemetis's short interest can also be evaluated against the total number of Aemetis shares, or, against the total number of tradable Aemetis shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aemetis's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Aemetis shares in existence, roughly 120 shares are currently held short) or 0.1374% of the tradable shares (for every 100,000 tradable Aemetis shares, roughly 137 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aemetis.

Find out more about how you can short Aemetis stock.

Aemetis share dividends

We're not expecting Aemetis to pay a dividend over the next 12 months.

Have Aemetis's shares ever split?

Aemetis's shares were split on a 4:1 basis on 14 June 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Aemetis shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Aemetis shares which in turn could have impacted Aemetis's share price.

Aemetis share price volatility

Over the last 12 months, Aemetis's shares have ranged in value from as little as $1.96 up to $27.44. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aemetis's is -0.4735. This would suggest that Aemetis's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aemetis has bucked the trend.

Aemetis overview

Aemetis, Inc. operates as a renewable natural gas and fuels, and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products. It owns and operates an ethanol facility in the California Central Valley near Modesto; and a renewable chemical and advanced fuel production facility on the East Coast of India. The company sells biodiesel and refined glycerin to transport companies, resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces and sells ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers solubles to dairies and feedlots as animal feed, as well as other health care and sanitary products, and industrial and potable alcohol for beverage spirits. In addition, it produces dairy biogas; and high-grade sanitizer alcohol and various feed products, as well as researches and develops efficient conversion technologies using waste feedstocks to produce biofuels and biochemicals.

Frequently asked questions

What percentage of Aemetis is owned by insiders or institutions?
Currently 6.746% of Aemetis shares are held by insiders and 62.802% by institutions.
How many people work for Aemetis?
Latest data suggests 164 work at Aemetis.
When does the fiscal year end for Aemetis?
Aemetis's fiscal year ends in December.
Where is Aemetis based?
Aemetis's address is: 20400 Stevens Creek Boulevard, Cupertino, CA, United States, 95014
What is Aemetis's ISIN number?
Aemetis's international securities identification number is: US00770K2024
What is Aemetis's CUSIP number?
Aemetis's Committee on Uniform Securities Identification Procedures number is: 00101P102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site